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Summary
B cells maintain homeostasis by balancing cell viabil-
ity and cell death. B lymphocytes are susceptible to
mitochondria- and receptor-initiated cell death at vari-
ous stages of peripheral differentiation and during
immune responses. The inducible transcription factor
NF-kB enhances cell viability by activating genes that
counteract both cell-death pathways. This review uses
characteristic features of NF-kB activation and down-
regulation to provide insight into the regulation of
B cell apoptosis in the periphery. In particular, the
temporal patterns of NF-kB induction, differences
between Rel family members, and the intersection
between canonical and noncanonical signaling path-
ways in keeping B cells alive are discussed.
Regulated cell proliferation and cell death are central to
lymphocyte development and the immune response.
The diversity essential for pathogen recognition is
generated by the assembly of antigen-receptor genes
from a random assortment of gene segments via V(D)J
recombination. The price of ensuring diversity is that
primary recombination events produce a range of re-
ceptor specificities of which only few are useful to the
individual. Cells that express useless, or harmful, recep-
tors are weeded out via altered receptor specificity or
programmed cell death. The ability to expand the right
clone for effective immune responses comes with the
necessity of removing unwanted cells once the danger
has passed. Furthermore, the process of cell elimination
must be tempered so that some cells that retain memory
of the encounter are preserved, yet it must be efficient
enough so as not to leave behind cells that may cause
autoreactivity.
Because of their importance in maintaining lympho-
cyte homeostasis, mechanisms of cell death, and how
they are countered by survival signals, have been exten-
sively studied. These studies have identified genes that
participate in, or inhibit, two major death-inducing path-
ways in lymphocytes. One pathway, referred to as cell
intrinsic, disrupts mitochondrial integrity (Green and
Kroemer, 2004; Strasser, 2005) and leads to cytochrome
c release and caspase activation. The other pathway,
referred to as cell extrinsic, is initiated at cell-surface
death receptors such as Fas and can circumvent mito-
chondria to directly activate effector caspases (Bidere
et al., 2006; Lavrik et al., 2005). What is less clear is
how the balance between apoptosis-inducing signals
and antiapoptotic gene expression is achieved to
*Correspondence: rs465z@nih.govproduce optimal immune responses. For example, it is
readily apparent that if cell death occurs too soon, the
immune response will be ineffective; conversely, a pro-
longed immune response is likely to cause inflammatory
problems. Thus, understanding how the life or death
choice is regulated in lymphocytes is essential for future
manipulation of dysregulated immune responses. The
objective of this review is to address the problem of
balance in B lymphocyte death from the perspective
provided by the properties of the transcription factor
NF-kB.
NF-kB Regulation
The inducible transcription factor NF-kB (Hayden and
Ghosh, 2004) protects against both forms of death by
activating the transcription of genes that encode
antiapoptotic proteins. From the demonstration more
than a decade ago of increased sensitivity of NF-kB-de-
ficient cells to tumor necrosis factor a (TNFa) or gen-
toxic-stress-induced death to more recent studies that
implicate NF-kB activation in tumorigenesis (Karin,
2006; Pikarsky and Ben-Neriah, 2006), the antiapoptotic
function of NF-kB has been documented in numerous
cell types and in response to diverse stimuli. NF-kB ac-
tivation involves phosphorylation of inhibitory IkB pro-
teins by the IkB kinases a and b [IKKa and IKKb (Bonizzi
and Karin, 2004)], leading to IkB degradation and release
of DNA-binding NF-kB, which translocates to the nu-
cleus to activate gene transcription. The canonical acti-
vation pathway, utilized by inducing agents such as
TNFa, IL-1, lipopolysaccaride (LPS), and antigen recep-
tors, activates IKKb with resultant degradation of IkBa,
IkBb, and IkB3. This pathway primarily activates NF-kB
heterodimers consisting of p50 (NFkB1) associated
with REL-A(p65) or REL. The noncanonical pathway, uti-
lized by lymphotoxin b, B cell-activating factor of the
TNF family (BAFF), and CD40, activates IKKa. This leads
to phosphorylation and proteolytic processing of the
C-terminal ankyrin domain of p100 and results in the
release of p52 (NFkB2)-REL-B heterodimers to activate
gene expression. Many NF-kB-inducing stimuli simulta-
neously trigger cell death, whereas genes that are acti-
vated by NF-kB are recurrently implicated in protecting
against cell death. Thus, the regulation of NF-kB re-
sponses is required for striking the right balance be-
tween cell viability and cell death. Because rules that
govern the choice will very likely vary with cell-types, in-
ducing regimens, cell-cycle status, etc., it is imperative
to understand NF-kB-dependent anti-apoptosis within
specific biological contexts.
Temporal Control of NF-kB Responses
The transient nature of many forms of NF-kB activation
is likely to be an important determinant of the duration
of cell viability. This feature, sometimes referred to as
postinduction repression, has been known for many
years in the context of NF-kB induction by TNFa. Several
mechanisms contribute to ensuring transient NF-kB in-
duction. One of the most important is via upregulation
of IkBa gene transcription by REL-A(p65), which leads
Immunity
872to de novo IkBa protein synthesis. The newly synthe-
sized IkBa protein is proposed to enter the nucleus, as-
sociate with Rel proteins, and export them to the cytosol
to terminate NF-kB-dependent gene transcription and
re-establish the resting state of cells (Banerjee and
Sen, 2006). Consequently, nuclear NF-kB lifetime is
prolonged in IkBa-deficient cells, or in the absence of
protein synthesis. Even this simple downregulatory
pathway is further modulated by posttranslational mod-
ification of Rel proteins. Acetylation of REL-A(p65) in-
hibits its interaction with IkBa and prevents its removal
from the nucleus, thereby resulting in increased NF-kB-
dependent transcription. NF-kB-dependent inducible
gene transcription is also regulated by nuclear protea-
somal degradation of REL-A(p65) (Saccani et al., 2004).
This regulatory pathway has been most clearly demon-
strated on cytokine gene promoters, where recruitment
of proteasomal components to the promoter suggests
that the promoter-bound transcription factor is de-
graded to terminate a response. Interestingly, REL-
A(p65) is targeted for nuclear degradation via phosphor-
ylation by IKKa (Lawrence et al., 2005).
In addition to active depletion of the transcription
factor from the nucleus, mechanisms are in place to
ensure that the re-generated cytosolic pool is not effi-
ciently re-activated. One NF-kB target gene induced
by TNFa is A20. This is a ubiquitin ligase that ubiquiti-
nates and marks for proteasomal degradation recep-
tor-interacting protein (RIP) (Boone et al., 2004; Wertz
et al., 2004), which is essential for TNFa receptor signal-
ing to the IKK complex. In the absence of RIP, TNFa
signaling to NF-kB is temporarily attenuated. The impor-
tance of this downregulatory mechanism is evident from
the systemic inflammation seen in A20-deficient mice
(Lee et al., 2000). An analogous situation occurs in T
lymphocytes stimulated via the T cell receptor (TCR).
TCR signals activate NF-kB via a heterotrimeric complex
consisting of the CARD-domain proteins Bcl-10 and
CARMA1, together with MALT1 (Weil and Israel, 2006).
In this pathway, Bcl-10 is targeted for lysosomal degra-
dation by a presently unknown mechanism (Scharsch-
midt et al., 2004). The consequent reduction in TCR
signaling to IKKb probably contributes to transient
REL-A(p65) induction in CD4+ T cells (Mittal et al., 2006).
It is important to note that these downregulatory mech-
anisms selectively affect the inducing stimulus. That
is, a T cell that has attenuated TCR signaling to NF-kB
by degrading Bcl-10 is still responsive to NF-kB induc-
tion by a different pathway, such as TNFa or IL-1.
Finally, NF-kB-dependent gene expression may also
be terminated via the generation of NFkB1(p50) homo-
dimers, which lack classical transcription-activation
domains. These proteins may serve as simple repres-
sors by obstructing DNA binding of transcriptionally
active Rel complexes that contain REL-A(p65) or REL.
Alternatively, p50 homodimers may recruit histone de-
acetylases (HDACs) to NF-kB-dependent promoters to
turn off genes by epigenetic means (Williams et al.,
2006; Zhong et al., 2002). Like NF-kB-dependent induc-
tion of A20 or IkBa genes, this also represents a feed-
back-inhibitory mechanism because the gene encoding
p105, the precursor to p50, is an NF-kB target. Thus,
multiple pathways ensure that the NF-kB response is
short-lived, although the relative importance of eachpathway will probably vary with cell type and the initiat-
ing stimulus.
However, not all inducers lead to transient NF-kB
activation. Among the best characterized is the long-
term response to lipopolysaccharide (LPS) via toll-like
receptor (TLR) 4. This has recently been shown to be
due to two independent pathways of NF-kB activation
downstream of TLR4 (Covert et al., 2005; Werner et al.,
2005). Although the NF-kB response to each pathway
oscillates as a result of IkBa feedback (Hoffmann and
Baltimore, 2006; Hoffmann et al., 2002), the temporal
distinction between them ensures continued NF-kB
activity. The duration of NF-kB has been modeled as
a function of the intensity and duration of IKKb activity
(Werner et al., 2005). Transient NF-kB inducers, such
as TNFa, lead to kinetically rapid activation and de-acti-
vation of IKKb. Long-term inducers, such as LPS, lead
to kinetically slower and lower levels of IKKb activation;
this mechanism may also apply to the persistent NF-kB
activation noted in certain classes of B lymphomas
(Davis et al., 2001). Importantly, variation between these
extremes provides the means for generating unique
kinetic patterns of NF-kB responses.
NF-kB Kinetics Affect Cellular Apoptosis
Two recent studies exemplify the intersection between
NF-kB cell biology and the regulation of apoptosis in
immune cells. Lawrence et al. (2005) showed that mac-
rophages from IKKa-deficient mice produced higher
levels of inflammatory cytokines in response to LPS
treatment. They traced the abnormality to extended
duration of nuclear REL-A(p65) in mutant as compared
to normal macrophages. In this case the kinetics of
REL-A(p65) downregulation from the nucleus (during
continued LPS stimulation) was altered because nuclear
p65 was not targeted for degradation in IKKa-deficient
macrophages. In addition to cytokine gene expression,
NF-kB-dependent antiapoptotic gene expression was
also elevated in these cells, resulting in extended cell
viability. The combination of elevated cytokine produc-
tion for longer periods of time translated into increased
morbidity of IKKa-deficient mice in response to group B
streptococcus or endotoxic shock.
In CD4+ T cells, continuous TCR signals first induce
and then downregulate REL-A(p65) from the nucleus
(Mittal et al., 2006). Loss of nuclear REL-A(p65) coin-
cides with the onset of Fas-initiated cell death, suggest-
ing that NF-kB-dependent antiapoptotic gene expres-
sion regulates cell viability. Consistent with this idea,
expression of three out of several putative NF-kB-
dependent antiapoptotic genes follows the kinetics of
NF-kB induction and downregulation. Although Bcl2l1
(Bcl-X) is one of these genes, ectopic expression of
Bcl-XL does not alter the kinetics of cell death, pro-
bably because Fas-initiated cell death bypasses the
mitochondria. Expression of one of the other genes,
Gadd45b, however, prolongs the viable phase of the
cells. Thus, transient NF-kB activation results in tran-
sient expression of antiapoptotic genes in these cells,
and programmed cell death occurs when these genes
are downregulated. Both observations suggest that
the duration of NF-kB activation has important cellular
consequences.
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B cells that emerge in the periphery after completing an-
tigen receptor gene rearrangements in the bone marrow
undergo further differentiation to become mature, func-
tional B cells. The most immature B cells in the periph-
ery, also referred to as transitional B cells, express the
AA4 cell-surface marker and are further subdivided
into T1-T3 subsets on the basis of IgM, CD21, and
CD23 expression (Thomas et al., 2006). A hallmark of im-
mature B cells, in particular T1 cells, is their extreme
sensitivity to apoptosis (Chung et al., 2003). Indeed,
the prevailing view is that T1 cells are programmed to
die unless positively selected to survive and differentiate
further (Cancro and Kearney, 2004; Levine et al., 2000).
This subset is also the target of negative selection sig-
nals which eliminate cells that express self-reactive
BCRs. Cell death by neglect or negative selection oc-
curs via the mitochondrial pathway by the action of
proapoptotic Bcl-2 family members Bak and Bax and
the BH3 domain-only protein Bim (Enders et al., 2003;
Oliver et al., 2006; Takeuchi et al., 2005). In mice with B
cell-specific double deletion of Bak and Bax, the num-
bers of immature AA4+ and mature follicular B cells are
higher than in controls, and these cells resist multiple
death-inducing stimuli, including BCR cross-linking and
cytokine withdrawal, in vitro. The phenotype of Bim-
deficient mice is similar, although the effects are less
accentuated than in the Bak and Bax double deficiency,
indicating partial compensation for the absence of Bim.
NF-kB Regulation of Immature B Cell Survival
A role for NF-kB in immature B cell survival is evident
from mouse mutations in Rel proteins (Gerondakis and
Strasser, 2003) and signaling intermediates in the
NF-kB activation pathway (Siebenlist et al., 2005). Rel
and Rela double deficiency blocks peripheral B cell
differentiation at the immature T1 stage, and cells that
remain are highly susceptible to death in vitro (Gross-
mann et al., 2000). The developmental defect is due to
reduced Bcl-2 expression and is overcome by trans-
genic expression of this gene. Single deficiency of either
REL or REL-A(p65) does not have this phenotype, indi-
cating that each of these Rel family members function-
ally compensates for the absence of the other. Double
deficiency of Nfkb1 and Nfkb2 genes blocks differentia-
tion at the immature T2 stage (Claudio et al., 2002). As
with other single-gene deficiencies of Rel family pro-
teins, the steady-state phenotypes of either Nfkb1 or
Nfkb2 gene deletions is subtle with regard to follicular
B cells; however, the number of marginal-zone B cells is
reduced (Cariappa et al., 2000) in the absence of Nfkb1,
and remaining cells in either single-gene deficiency are
sensitive to apoptosis (Franzoso et al., 1998; Grumont
et al., 1998). Because p50 (derived from Nfkb1) and
p52 (derived from Nfkb2) proteins are downstream ef-
fectors of the canonical and noncanonical NF-kB signal-
ing pathways, respectively, these observations suggest
that both pathways contribute to survival and differenti-
ation of immature B cells. Accordingly, mutation of sig-
naling kinases in each NF-kB pathway also blocks the
generation and maintenance of mature B lymphocytes.
IKKa-deficient precursors, whose only discernible
NF-kB defect is a reduced amount of p52, reconstitute
fewer B cells than normal precursors because of a blockat the T2 stage of differentiation (Kaisho et al., 2001;
Senftleben et al., 2001). Downregulation of the canonical
pathway by conditional deletion of Ikbkb (Li et al., 2003;
Pasparakis et al., 2002) or Ikbkg (Sasaki et al., 2006) re-
sults in a developmental block at the T1-to-T2 transition.
The stronger phenotype of single IKK deficiencies com-
pared to NFkB1 or NFkB2 deficiency probably reflects
similar DNA-binding properties of p50 and p52 homo-
dimers, respectively, rather than functional overlap
between IKKa and IKKb.
B Cell Receptor Regulation of B Cell Survival
The B cell receptor (BCR) provides survival signals es-
sential for maintaining the mature B cell pool. This was
first demonstrated by inducible deletion of the Igh
gene in the periphery; this deletion leads to a loss of B
cells (Lam et al., 1997). These observations were further
substantiated recently by conditional deletion of either
Igh or the signal-transducing Cd79a (Iga) genes (Kraus
et al., 2004; Meffre and Nussenzweig, 2002). A role for
BCR signaling is evident in the most immature T1 transi-
tional B cells. Tze et al. (2005) found that deleting Cd79a
in immature IgMhi B cells resulted in de-differentiation as
evidenced by transcriptional activation of genes nor-
mally expressed in pro-B cells. They proposed that the
BCR maintained the differentiation state of immature
B cells. In addition, deficiency of several cytoplasmic
molecules implicated in BCR signaling, such as Btk,
PLCg, PI3K (Su et al., 2004), and the adapter proteins
BLNK and BCAP (Koretzky et al., 2006; Kurosaki, 2002;
Yamazaki and Kurosaki, 2003) attenuates peripheral dif-
ferentiation at the immature stage, although the impact
of each gene mutation varies.
The close correspondence between a requirement for
canonical NF-kB components and BCR signaling in
transitional cells suggests that the BCR may induce
NF-kB in these cells. However, although the case for
BCR signaling in transitional cells is strong (Fuentes-
Panana et al., 2004), the evidence that these signals cul-
minate in NF-kB activation is weaker. The idea that BCR
signals induce NF-kB is supported by, in addition to the
phenotype of NF-kB-deficient mice, the observation that
the maturation defect in BCAP-deficient B cells involves
NF-kB and, in particular, REL (Yamazaki and Kurosaki,
2003). In contrast, genetic deletion of CARMA1, Bcl-
10, or MALT1 does not substantially affect follicular B
cell maturation (Hara et al., 2003; Newton and Dixit,
2003; Ruefli-Brasse et al., 2003; Ruland et al., 2001;
Xue et al., 2003), which has been taken to indicate that
BCR-induced survival signals are not mediated by
NF-kB. Although these proteins are essential compo-
nents of antigen-receptor signaling to NF-kB in mature
B cells, we cannot rule out the possibility that BCR-in-
duced survival signals activate NF-kB by a route that
does not involve the Bcl-10-CARMA-1-MALT-1 com-
plex. Mechanistically, this may be because the BCR in
immature cells is not associated with lipid rafts (Chung
et al., 2001), or it may simply be because the nature of
tonic signaling is different from what is recapitulated
by BCR crosslinking in vitro (Monroe, 2006). Function-
ally, the result may be reduced IKKb activation that al-
lows persistent NF-kB-dependent antiapoptotic gene
expression that is essential for maintaining B cell viabil-
ity. Overall, it remains plausible that BCR signals result
Immunity
874Figure 1. Proposed NF-kB Control of Periph-
eral B Cell Maturation and Maintenance
BCR signals in T1 transitional cells (top left)
may activate canonical NF-kB proteins, either
in response to substrate recognition or by
‘‘tonic’’ signaling, for extended duration as
represented in the left graph (Y axis = NF-kB,
X axis = time, dotted line represents the sur-
vival threshold). At this stage there is minimal
noncanonical signaling, as represented by
the right graph. Extensive BCR crosslinking
(top right) leads to acute, but transient, NF-kB
induction; during the downregulation phase,
NF-kB amounts may drop below the survival
threshold, resulting in apoptosis. While
NF-kB expression is high, cells survive and
have the opportunity to undergo receptor
editing, particularly in the protective microen-
vironment of the bone marrow. NF-kB-medi-
ated survival allows progression to the T2
stage (middle), where BAFF-R is first ex-
pressed. Continued canonical signaling via
the BCR generates p100 (NFkB2), which
serves as the substrate for the IKKa-depen-
dent noncanonical NF-kB pathway initiated
at BAFF-R. This induces p52-REL-B com-
plexes as represented by the right graph
(green line). BAFF-R signals activate multiple
survival pathways, such as Akt, Pim2, and
PKCd, and downregulate the proapoptotic
protein Bim. In addition, BAFF-R signals in-
duce CD21 gene expression to generate the
BCR coreceptor complex (bottom). The pres-
ence of this complex may enhance BCR sig-
nals to elevate persistent canonical NF-kB
(left graph) and NF-kB-dependent survival-
gene expression. Increased BCR signals
may feed into the BAFF-R pathway by in-
creasing BAFF-R expression (indicated by
arrow between BCR and BAFF-R). As a con-
sequence, a self-reinforcing loop is estab-
lished, with the BCR enhancing the BAFF-R
pathway and vice-versa. Perhaps the loop is
held in check by BAFF concentrations and
BCR substrate recognition being limited
in vivo.in immature B cell survival by inducing NF-kB by the
canonical pathway. In this scenario, T1 cells that migrate
to the periphery lose bone-marrow-derived survival
signals, thus tilting the balance in favor of mitochon-
dria-initiated apoptosis. A proportion of these cells are
rescued to differentiate further if they receive a BCR
signal of sufficient strength to counteract cell-intrinsic
apoptosis by inducing NF-kB-dependent Bcl-2 family
genes (Figure 1, top left).
This kind of survival signaling is overridden in the face
of extensive BCR crosslinking, which leads to apoptosis
of immature T1 cells. Defective NF-kB activation in these
cells has been suggested as a possible cause for their
sensitivity to cell death based on reduced induction of
Bcl-X and A1 genes (Feng et al., 2004; Su and Rawlings,
2002). Moreover, reduced PKC activation, as a conse-
quence of reduced PIP2 hydrolysis (King et al., 1999),
may also result in ineffective NF-kB activation in these
cells. In this model, BCR crosslinking in T1 cells acti-
vates proapoptotic pathways, but not antiapoptotic
mechanisms to neutralize them. However, IkBa degra-dation in response to BCR crosslinking is comparable
in T1, T2, and mature B cells (W. Khan, personal commu-
nication). This suggests that BCR crosslinking may
induce acute, but transient, NF-kB activation (Figure 1,
top right). While NF-kB is up, the cells survive; however,
during the downregulation phase initiated by REL-
A(p65)-dependent IkBa gene transcription, the bolus of
newly synthesized IkBa may reduce NF-kB amounts
below the threshold required to maintain effective
antiapoptotic gene expression. When this happens,
the proapoptotic activity of proteins such as Bim domi-
nate, and this leads to cell death. Self-recognition by im-
mature B cells in the bone marrow also initiates receptor
editing (Louzoun et al., 2002), particularly at the Igk light-
chain gene locus. The heightened NF-kB response may
also induce RAG gene expression essential for this pro-
cess (Amin and Schlissel, 2005; Verkoczy et al., 2005),
and the k locus itself may be targeted via NF-kB binding
to the k gene intron enhancer. The transient nature of
NF-kB activation in response to BCR crosslinking would
allow a finite window of opportunity for these processes
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tective effects of the bone-marrow microenvironment
(Sandel and Monroe, 1999) may prolong NF-kB activa-
tion or provide compensatory means to maintain cell
viability after NF-kB downregulation.
BAFF-R Regulation of B Cell Survival
In addition to the BCR, mature B cell survival requires
the ligand-receptor pair BAFF and BAFF-receptor
(BAFF-R) (Crowley et al., 2005; Woodland et al., 2006).
An essential role of BAFF in vivo was inferred from the
markedly reduced numbers of B cells in mice that lack
either the ligand or the receptor. Additionally, treatment
of normal mice with receptor fusion proteins that se-
questered soluble BAFF also led to rapid loss of B cells.
Based on in vitro studies, these defects were attributed
to BAFF-dependent B cell survival (Smith and Cancro,
2003). The survival defect in the absence of BAFF is
largely overcome by transgenic expression of Bcl-XL,
indicating that BAFF-R signals attenuate mitochon-
dria-initiated death (Amanna et al., 2003). During periph-
eral differentiation, BAFF-R is highest at and beyond the
T2 transitional stage; accordingly, differentiation is com-
promised between the T1 and T2 stages in BAFF-, or
BAFF-R-, deficient mice. The observation that BCR
crosslinking on mature B cells upregulates BAFF-R ex-
pression (Smith and Cancro, 2003) raises the possibility
that BCR activation in T1 cells in vivo may induce
BAFF-R expression in addition to NF-kB-dependent
survival genes, thereby allowing progression to the T2
stage (Figure 1, middle). The strength of the BCR signal
would likely be key in determining whether BAFF-R
expression, and BAFF-R-dependent survival signals,
could overcome T1 cell death initiated at the BCR.
Multiple pathways regulate survival by BAFF beyond
T2 transitional cells. One of the first to be characterized
was the noncanonical NF-kB pathway that generates
p52-REL-B nuclear complexes by IKKa-dependent
NF-kB processing (Claudio et al., 2002; Kayagaki et al.,
2002). However, antiapoptotic gene targets of p52-
REL-B heterodimers remained unclear until recently.
The studies of Enzler et al. (2006) now show that expres-
sion of Pim-2, an antiapoptotic serine-threonine kinase,
is strictly dependent on IKKa and p52, implicating this
gene as a possible downstream target of p52-REL-B.
The block in peripheral B cell differentiation, and the ab-
sence of BAFF-induced cell viability in vitro, in cells that
lack IKKa further underscores the importance of this
pathway (Enzler et al., 2006). BAFF-induced expression
of NF-kB target genes Bcl2l1 (Bcl-X) and Bcl2a1a (A1)
is also reduced in IKKa- and p52-deficient B cells, but
the functional significance of this decrease is unclear.
Instead, Woodland and colleagues find that Mcl-1 is es-
sential for BAFF-R-dependent survival signaling in vitro
(R.T. Woodland, personal communication).
In addition to activating noncanonical NF-kB, BAFF
signals attenuate cell death by directly targeting Bim.
BAFF-initiated ERK activation results in Bim phosphor-
ylation and degradation (Craxton et al., 2005), whereas
BAFF-induced Akt activation (Patke et al., 2006) may
reduce Bcl2l11 (Bim) gene transcription by blocking
the transcription factor. Both mechanisms lower Bim
levels and thus favor cell survival. Additionally, Akt is
known to increase NF-kB induction via the canonicalpathway in various cell types. Therefore, it is possible
that BCR-induced NF-kB induction, and NF-kB-depen-
dent survival gene expression, is enhanced by Akt
activated via BAFF-R. BAFF also activates Pim-2 gene
expression as described above, and this is linked to
cell survival via inactivation of the proapoptotic protein
Bad (Fox et al., 2003). Interestingly, a closely related pro-
tein, Pim-1, has been previously implicated in NF-kB
function (Hammerman et al., 2004; Zhu et al., 2002).
Finally, cytoplasmic redirection of PKCd is another
mechanism by which BAFF regulates B cell survival
(Mecklenbrauker et al., 2004). This pathway is also acti-
vated by constitutive IKKb expression in BAFF-R-defi-
cient mice, suggesting a link to NF-kB (Sasaki et al.,
2006). Overall, BAFF-BAFF-R signals attenuate several
mitochondria-targeted proapoptotic mechanisms and
may thereby create a milieu in which antiapoptotic
genes function more effectively. The close coincidence
of multiple BAFF-induced survival pathways with previ-
ously identified NF-kB targets indicates that BAFF-
R-initiated signals intersect directly and indirectly with
NF-kB to regulate peripheral B cell survival.
Mechanisms of BCR- or BAFF-R-initiated survival
signals must explain the central fact that both pathways
are simultaneously required for B cell survival in vivo.
Several NF-kB-dependent synergistic interactions be-
tween the two pathways can be envisaged based on
available data. The BCR may feed into the BAFF-R path-
way by regulation of BAFF-R expression and by canon-
ical NF-kB-dependent p100 gene transcription to create
a pool of p100-REL-B complexes that are targeted by
BAFF-R-dependent activation of the noncanonical path-
way. As suggested above, this part of the synergy may
be initiated in T1 cells. BAFF-R signals at the T2 stage
have the potential to reinforce the canonical NF-kB
pathway by activating Akt and CD21 gene expression
(Gorelik et al., 2004). Akt is known to accentuate
NF-kB induction, and CD21 may participate by lowering
the threshold of BCR signaling via the CD19/CD21 co-
receptor complex (Rickert, 2005). The net effect of
such mutual reinforcement is elevated NF-kB, and NF-
kB-dependent antiapoptotic gene expression, in mature
cells (Figure 1, bottom). It is tempting to speculate that
the resulting high basal expression of NF-kB is what is
visualized as constitutive NF-kB uniquely in B lympho-
cytes. In this scenario canonical NF-kB is the major me-
diator of antiapoptotic gene expression in a cellular en-
vironment where proapoptotic pathways have been
downregulated by BAFF-R signals; thus, loss of either
signaling pathway leads to cell death.
Recently, Rajewsky and colleagues provided strong
evidence that activation of the canonical NF-kB pathway
restores peripheral B cell differentiation in BAFF-R-defi-
cient mice (Sasaki et al., 2006). They expressed a consti-
tutively active form of IKKb in the B lineage, and this
resulted in increased nuclear expression of canonical
NF-kB components REL-A(p65) and REL, but not p52.
This genetic manipulation restored peripheral B cell dif-
ferentiation in BAFF-R-deficient mice, suggesting that
the canonical NF-kB pathway was sufficient for B cell
survival. These observations are consistent with the
crux of the above model, in which the ultimate result of
BAFF-R and BCR synergy is canonical NF-kB activation.
Mechanistically, constitutive IKK-2 expression may
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activating the canonical pathway via the BCR.
B Cell Survival during the Immune Response
The mitochondrial cell-death pathway continues to play
a central role in B cell survival at multiple stages of the
immune response. B cells respond to antigen in the pres-
ence, or absence, of T cell help. Type-II T-independent
antigens initiate responses by extensive crosslinking of
the BCR, leading to short-term antibody production
without significant affinity maturation. The initial phase
of the T-independent responses has been mimicked
in vitro by BCR crosslinking with anti-immunoglobulin
(anti-Ig). An extensive literature documents the effects
of anti-Ig, particularly the elucidation of cytosolic signal-
ing pathways mediated by kinases and phosphatases
(Dal Porto et al., 2004; Jumaa et al., 2005). Farther down-
stream, cell proliferation is one parameter used for read-
ing out B cell activation. Although anti-Ig stimulates B
cell proliferation in vitro, a substantial proportion of
mature B cells also die in response to BCR crosslinking.
The effect, however, is less pronounced than in imma-
ture B cells. This form of death is reduced in transgenic
mice that express antiapoptotic Bcl-2 family members,
indicating that it is driven by mitochondria (Enders
et al., 2003). Pro-apototic Bim is again a key player in
this process; it is increased by transcriptional as well
as posttranscriptional mechanisms in response to BCR
crosslinking (Enders et al., 2003). Thus, Bim-deficient B
cells are largely protected against anti-Ig-induced death
regardless of their peripheral differentiation stage.
The NF-kB family member REL plays a crucial role in
alleviating BCR-induced death of mature B cells. Pheno-
typically mature B cells from Rel-deficient mice die in
response to BCR crosslinking in a manner reminiscent
of immature B cells. This is because of defective Bcl-x
and A1 gene transcription, and cell death can be averted
by transgenic Bcl-2 or Bcl-XL expression (Grumont et al.,
1999; Owyang et al., 2001). Although it is likely that Bim
is the major death-inducing protein in REL-deficient
B cells, this has not been directly proven. These obser-
vations indicate that REL-dependent Bcl-XL or A1 in-
duction counteracts Bim-induced mitochondrial dys-
function in wild-type B cells. If the outcome favors
REL-dependent gene expression, the cells survive and
proliferate; if not, Bim-induced death ensues. The extent
of B cell death in response to BCR suggests that the out-
come disproportionately favors Bim-induced death, un-
less additional antiapoptotic signals neutralize it. Signals
that enhance B cell viability during anti-Ig crosslinking
include LPS, BAFF-R, and CD40 (Smith and Cancro,
2003); each of these stimuli can alter NF-kB-dependent
antiapoptotic gene expression (Figure 2), or directly
downregulate Bim, for example via Erk-dependent phos-
phorylation and degradation. In addition to cell survival,
REL is also essential for BCR- or CD40- (see below)
induced B cell proliferation in vitro. This has been attrib-
uted to REL-dependent induction of E2F3 and cyclin E
to mediate G1-S progression (Cheng et al., 2003).
What distinguishes REL from other NF-kB family
members, particularly REL-A(p65), in its ability to pro-
vide survival signals to BCR-activated mature B cells?
One possibility is that Bcl-XL and A1 gene promoters
are uniquely responsive to REL in B cells. This appearsto be unlikely, however, because CD40 stimulation
induces Bcl-XL gene transcription in REL-deficient B
cells. An alternative possibility is that REL may be in-
duced for a longer duration than REL-A(p65) in response
to BCR crosslinking (Figure 2). The proposed difference
in kinetics of REL-A(p65) versus REL expression is
based on two considerations. First, analogous to our
observations in CD4+ T cells, REL-A(p65) nuclear induc-
tion after BCR stimulation is likely to be short-lived be-
cause of new IkBa synthesis and IkBa-mediated down-
regulation. Second, REL induction in both B and T cells
is calcineurin dependent (Venkataraman et al., 1995).
This part of the REL response is due to new Rel gene
transcription and translation and requires the slow
Ca++ influx that is regulated by Btk in mature B cells (Baj-
pai et al., 2000; Petro et al., 2000). Transcriptional induc-
tion of the Rel gene in response to the T cell receptor
was recently shown to be mediated by the transcription
factor NFAT (Grumont et al., 2004). A similar mechanism
may apply in BCR-stimulated B cells. As a consequence
of de novo Rel transcription, higher expression of
REL present in activated cells may override IkBa-
mediated downregulation. The transient REL-A(p65)
response, and more long-term c-REL response, im-
plicates c-REL-containing NF-kB proteins as the ma-
jor mediators of antiapoptotic gene expression after
extended BCR stimulation. Thus, in REL-deficient B
cells, NF-kB-dependent survival signals are short lived.
Protracted REL induction in mature B cells may also
contribute to the differential sensitivity of immature
versus mature B cells to BCR-induced death. Immature
B cells do not induce high amounts of REL (Feng et al.,
2004), presumably because of diminished Rel gene tran-
scription. In the absence of de novo REL protein synthe-
sis, its nuclear induction is likely to be short-lived
like that of REL-A(p65), leading to inefficient long-term
Figure 2. Patterns of NF-kB Activation by B Cell Surface Receptors
The graphs summarize patterns of NF-kB activation by four impor-
tant NF-kB-inducing cell-surface receptors (Y axis = NF-kB level;
X axis = time; red line = NF-kB induced by the canonical pathway;
green line = NF-kB induced by the noncanonical pathway; blue
line = REL induced by de novo gene expression). More than one
receptor may be activated during a typical immune response (for
example, BCR plus TLR in TI-I responses or BCR plus CD40 in TD
responses), resulting in appropriately altered patterns of NF-kB
activation.
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877transcriptional activation of NF-kB-dependent antia-
poptotic genes. Additionally, immature B cells exhibit
an imbalance in PI3K and PTEN activity in response to
BCR crosslinking, in part through high levels of phos-
pholipid phosphatase PTEN (H.-C. Liou, personal com-
munication). By dephosphorylating PIP3 to PIP2, PTEN
reduces Akt kinase activity, which may influence the
cellular outcome by elevating proapoptotic pathways
such as that involving Bim and by reducing NF-kB
induction. The combined effect of accentuated apopto-
sis and transient NF-kB-dependent antiapoptotic gene
expression would make these cells particularly sensitive
to BCR crosslinking. In mature B cells the converse
combination of increased Akt activity, due to PI3 kinase
function, and temporally extended nuclear REL expres-
sion, due to Btk and PLCg function, would favor cell
viability over apoptosis.
T-Dependent B Cell Responses
Affinity maturation of the antibody response, and gener-
ation of switched antibody isotypes, requires T cell help
(McHeyzer-Williams et al., 2006). CD4+ T cells are acti-
vated by peptide-MHCII complexes on antigen-present-
ing cells, costimulatory signals conveyed via CD80 and
CD86, and inflammatory cytokines. This occurs in the
T cell-enriched regions of the secondary lymphoid or-
gans and leads to clonal selection and proliferation.
Concurrently, antigen-specific B cells must be activated
in the B cell-rich follicles of the spleen in response to
immune complexes bound to follicular dendritic cells
(FDC). In this way, costimulatory effects of the CD19-
CD21 complex may help to overcome anergy- or apopto-
sis-inducing effects of the BCR alone. In a crucial next
step, antigen-activated B and T cells must come to-
gether to initiate T-dependent B cell responses. One
route by which the right cells find each other is by B
cell-mediated antigen presentation to cognate T cells.
The NF-kB milieu of B cells that receive T cell help
differs from that of B cells undergoing T-independent
activation primarily because of signaling via CD40.
CD40, a cell-surface molecule related to TNF receptors,
is constitutively expressed on mature B cells. Its ligand,
CD40L (CD154), is also a plasma-membrane protein that
is expressed only on activated T cells. Thus, B cells en-
countering activated T cells in the spleen leads to CD40
signaling that activates both canonical and noncanoni-
cal NF-kB pathways persistently (Zarnegar et al., 2004)
(Figure 2). The canonical NF-kB pathway mediates B
cell survival via induction of antiapoptotic Bcl-2-family
genes such as Bcl-XL. Unlike BCR crosslinking, how-
ever, Bcl-XL induction in response to CD40 does not
require REL, presumably because of the extended dura-
tion of REL-A(p65) induction. However, REL activated by
the canonical pathway remains essential for CD40-
dependent proliferation in vitro (Zarnegar et al., 2004).
Furthermore, CD40 also activates PI3 kinase, which
may attenuate other proapoptotic pathways. The overall
result is that CD40 provides long-term survival signals to
B cells and induces higher levels of B cell proliferation
than are seen with anti-Ig crosslinking alone. It is inter-
esting to note that despite being a relatively strong
inducer of the canonical NF-kB pathway, CD40 leads
to long-term REL-A(p65) activation. This could be be-
cause CD40 signals to IKKb are enhanced by Akt, whosesimultaneous activation (Andjelic et al., 2000; Calder-
head et al., 2000) results in increased IkBa turnover
and, therefore, less effective IkBa-dependent down-
regulation of REL-A(p65). Additionally, unlike antigen-
receptor- or TNF-R-initiated NF-kB activation pathways,
the CD40 signal itself may not be subject to effective
feedback inhibition (Moore and Bishop, 2005).
CD40 also upregulates Fas on B cells, making these
cells for the first time susceptible to both mitochondria-
and death receptor-initiated apoptosis. The importance
of the latter pathway is reflected in dysregulation of
humoral immunity and autoantibody production in the
absence of Fas. Fas-induced death of B cells is antago-
nized by signals initiated at the BCR (Rothstein et al.,
1995); such signals must exceed a threshold to be pro-
tective (Foote et al., 1998; Mizuno et al., 2003). This
may be one reason why tolerized B cells, which have at-
tenuated BCR signaling, are particularly sensitive to
Fas-dependent apoptosis in vivo (Rathmell et al., 1995).
Several studies also indicate a role for Fas in suppress-
ing the early generation of antibody-secreting cells in
transgenic mice that express autoreactive BCRs (Chen
et al., 2006; Culton et al., 2006; William et al., 2006).
The ultimate breakthrough from tolerance in these
animals may involve mutation of BCRs to higher-affinity
somatic variants that effectively protect against Fas-
mediated death. Cflar (c-FLIP), an NF-kB target gene
that inhibits caspase 8 activation in the DISC down-
stream of Fas, is considered a primary mediator of the
protective effects of the BCR (Hennino et al., 2000;
Wang et al., 2000). Interestingly, CD40 itself has been
proposed to antagonize Fas under some circumstances
by inducing another NF-kB-dependent gene, Gadd45b
(Zazzeroni et al., 2003). Several other mechanisms
have been shown to protect B cells from Fas; these in-
clude IL-4 initiated signals and inducible proteins such
as FAIM and Bcl-XL (reviewed in Mizuno et al., 2003).
The diversity of protective pathways have led to the
categorization of B cells as type II with regard to Fas
signaling, in which both mitochondria- and caspase-
8-initiated death pathways contribute substantially to
Fas-dependent apoptosis (Bidere et al., 2006).
Recently, the coreceptor complex associated with
BCR signaling was shown to be a means of crossing
the protective threshold. Barrington et al. (2005) found
that B cells activated by medium-affinity antigens sur-
vived in spleen follicles only if they expressed CD21;
otherwise, these cells were eliminated via the Fas path-
way. In contrast, high-affinity antigen-stimulated B cells
did not require CD21 to survive, suggesting that these
cells crossed the protective threshold without corecep-
tor help. Coreceptor-dependent survival was proposed
to be mediated by c-FLIP. Because this is a known
NF-kB target gene, coreceptor stimulation may increase
NF-kB function in activated B cells. This possibility par-
allels the situation in CD4+ T cells, where costimulation
via CD28 increases the amount of NF-kB in comparison
with activation by the TCR alone (Kane et al., 2002;
Schmitz and Krappmann, 2006). The NF-kB effect in
CD4+ T cells is strictly costimulatory in that CD28 alone
does not activate this pathway, and it is mediated by
PI3 kinase-dependent Akt activation. Narayan et al.
(2006) have proposed that activated Akt directly inter-
acts with CARMA1 in the TCR signaling cascade to
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878increase IKK activity, and thereby NF-kB. Because CD19
also stimulates PI3K and Akt (Otero et al., 2001; Wang
et al., 2002), it is possible that Akt synergizes with the
BCR-initiated canonical NF-kB pathway to enhance
NF-kB activation and NF-kB-dependent gene expres-
sion. Moreover, CD19 has been shown to activate Btk
(Fujimoto et al., 2002), which is another kinase known
to impact BCR-induced NF-kB. Cumulatively, these
observations are consistent with the idea that the protec-
tive role of the BCR against Fas-initiated cell death is
mediated by NF-kB-dependent antiapoptotic gene ex-
pression; coreceptor stimulation may accentuate the
NF-kB response when BCR signals alone are insufficient.
In keeping with the proposed protective role of NF-kB
against Fas, a major signaling defect in anergic B cells
is reduced NF-kB activation (Jun and Goodnow, 2003).
NF-kB Function in the Germinal Center
Antigen-specific B-T interaction in the T-rich zone of the
spleen leads to cell proliferation. One of the choices
open to the expanded B cell pool is to terminally differen-
tiate into short-lived plasma cells by activating the
transcriptional repressor Blimp-1 (Shapiro-Shelef and
Calame, 2004). Another choice is to migrate back into
follicles to establish germinal centers (GCs). GCs are
highly specialized structures generated as a result of
cell-cell and chemokine-based interactions among
FDC, B cells, and T cells. Here B cells undergo somatic
hypermutation (SHM) and class-switch recombination
to produce high-affinity antibodies with the requisite
effector function. Both processes are the result of exten-
sive GC B cell proliferation that creates substrates for the
mutagenic action of activation-induced deaminase (AID)
at the Ig loci. Subsequent selection of the highest-affinity
variants and death by apoptosis of unselected cells are
hallmarks of the GC reaction. CD40-CD40L interactions
on B and T cells, respectively, are required continuously
to generate and maintain GCs. Additional proliferative
vigor is provided by Bcl-6, a transcriptional repressor
that is expressed specifically in GC B cells (Fujita et al.,
2004; Phan et al., 2005). Bcl-6 is proposed to directly
block p53 gene transcription(Phan and Dalla-Favera,
2004), and thereby indirectly downregulate p53-regu-
lated cell-cycle inhibitors. The effects of transgenic
Bcl-2 and Bcl-XL expression on GC cells suggests that
cell death in GCs is largely mediated by the mitochon-
drial pathway. In contrast, Fas probably does not con-
tribute to the bulk of cell death in the GC, but it may
help to counterselect unwanted specificities (Mizuno
et al., 2003).
Both canonical and non-canonical NF-kB pathways
have been implicated in GC function. A role for CD40-
induced c-FLIP expression has been suggested as
a survival pathway based on the observation that GC
cell death in vitro coincides with loss of c-FLIP expres-
sion (Hennino et al., 2001; van Eijk et al., 2001). Lack of
Bcl-XL induction via the BCR is proposed to be the basis
for short-lived GCs composed of CD45-deficient B cells
(Huntington et al., 2006). Thus, consistent with the
observations in vitro, survival signals appear to be trans-
mitted via the canonical NF-kB pathway. An important
role for the noncanonical pathway is inferred from
defective GC formation in BAFF-R- (Rahman et al.,
2003; Vora et al., 2003) and p52-deficient (Franzosoet al., 1998) mice, as well as in mice reconstituted with
IKKa-deficient cells (Kaisho et al., 2001; Senftleben
et al., 2001). Although the noncanonical pathway may
also provide survival signals to B cells, its unique role
is more likely to be in regulating chemokines and recep-
tors involved in the organization of GC architecture (Bo-
nizzi et al., 2004). It is interesting that activation of this
pathway by CD40 does not compensate for BAFF-R-de-
ficiency, suggesting that the requirement for CD40 and
BAFF-R may be spatially or temporally segregated.
Although these mechanisms operate in B cells, inhibit-
ing the canonical NF-kB pathway in FDC also adversely
affects the GC reaction and affinity maturation (Victora-
tos et al., 2006). The proposed mechanism for this effect
is via induction of cell-adhesion molecules that promote
B cell viability.
The characteristic features of NF-kB-dependent
gene expression may play an important role in the GC.
Persistent canonical NF-kB activation via CD40-CD40L
interactions is a good candidate for survival and prolifer-
ative signals that initiate the GC reaction (Figure 3, arrow
‘‘a’’). The extent of proliferation may be controlled by
attenuation of CD40 signaling, perhaps as a result of lim-
ited availability of cognate T cells or negative regulators
of CD40 (Aiba et al., 2006; Qian et al., 2004). When CD40
signals ceased, NF-kB and NF-kB-dependent antiapop-
totic genes would be downregulated, ultimately leading
to cell death (Figure 3, arrow ‘‘b’’). This is reminiscent of
growth-factor-withdrawal-induced CD4+ T cell death
after primary clonal expansion (Marrack and Kappler,
2004) and may account for the bulk of cell death in the
GC. By analogy, this kind of cell death would proceed
by the mitochondrial pathway, for which there is good
evidence as described above. Therefore, Bcl-2-family
genes, such as Bcl-XL, would be primary mediators of
cell survival. A period of cell viability following each
round of proliferation, determined by the kinetics of
downregulation of antiapoptotic proteins, would pro-
vide the opportunity for AID function and selection.
Renewed BCR signaling, if it occurs within the limited
viable phase, has the potential to rescue a fraction of
these cells from programmed cell death (Figure 3,
arrows ‘‘c’’ and ‘‘d’’). Such a signal can induce two
NF-kB-dependent outcomes via the canonical pathway.
First, by reactivating Bcl-XL (and related antiapoptotic
genes), the signal may extend the lifetime of cells and
thereby increase the likelihood of their receiving T cell
help for another proliferative burst. Second, by activat-
ing genes such as those encoding c-FLIP and GADD45b,
the BCR may protect cells from Fas-mediated death
when they re-encounter CD4+ T cells. Although these
genes only temporarily extend cell viability, the dual
level of protection thus generated (against cell-intrinsic
and cell-extrinsic apoptosis) may play a role in the
maturation of the B cell response. Altered patterns of
SHM in Bcl-2 transgenic mice is consistent with reduced
selective pressure in the absence of cell-intrinsic death
(Hande et al., 1998; Kuo et al., 1997). However, affinity
maturation does occur in these mice, indicating that
other forms of cell death must be overcome if high-avid-
ity BCRs are to be selected. A CD19 mutation that
prevents PI3 kinase activation reduces affinity matura-
tion, suggesting a role for the coreceptor in the selection
process (Wang and Carter, 2005). In the absence of
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879Figure 3. Hypothesized NF-kB-Regulated
Survival Signaling during T-dependent
Responses
CD40 stimulation induces long-term NF-kB
activation via both canonical and noncanoni-
cal pathways (arrow labeled ‘‘a’’). The graph
represents canonical NF-kB activation (Y
axis = NF-kB amount, X axis = time). A dotted
line represents the NF-kB-dependent survival
threshold), which is essential for survival and
proliferation. Loss of CD40 signals leads to
decay of NF-kB, and NF-kB-dependent sur-
vival-gene expression (graph next to arrow
‘‘b’’; a yellow line represents the state of
NF-kB activation during the preceding phase;
a red line represents NF-kB downregulation
that occurs during phase ‘‘b’’). Cells die (indi-
cated by broken outlines) when NF-kB levels
fall below a threshold. The majority of cells
generated by proliferation may die at this
stage by a cell-intrinsic mechanism. A small
proportion of cells that bind antigen on FDC
will reactivate NF-kB via the BCR. Two possi-
ble NF-kB outcomes of BCR signaling are
considered. Recognition of limiting antigen
(arrow ‘‘d’’) may activate low-level, persistent
NF-kB, which if it exceeds the survival thresh-
old will lengthen the viable phase of these
cells (represented in graph next to arrow
‘‘d’’). As a consequence, the probability of re-encountering T cell help increases. BCR avidity, which determines the level of NF-kB induction,
may establish protection against one, or both, cell-death pathways as described in the text. Alternatively, extensive BCR crosslinking (arrow
‘‘e’’) may result in NF-kB downregulation below the survival threshold (represented in graph next to arrow ‘‘e’’), thereby leading to cell death.
In this way, limiting antigen concentration is crucial for an effective response.CD19 signaling, survivors may be stochastically
selected from the expanded pool, and this may lead to
the observed somatically mutated, but antigenically
unselected, GC population.
The observation that high antigen amounts result in
death of antigen-specific GC B cells (Han et al., 1995;
Pulendran et al., 1995; Shokat and Goodnow, 1995) sug-
gests that positive selection at this stage is stringently
regulated. Organization and immune-complex presen-
tation by the FDC network may play an important role
in this process. In addition to expressing NF-kB-depen-
dent cell-adhesion molecules, the FDC may also regu-
late the level and distribution of antigen for B cell recog-
nition. Limiting antigen concentration allows for rescue
of cells that express the highest avidity BCRs and mini-
mizes the chance of extensive BCR crosslinking that
may induce apoptosis. If BCR-induced antiapoptotic
gene expression plays a role in selection as described
above, then a high dose of antigen may trigger cell death
by acute, and therefore transient, NF-kB induction
(Figure 3, arrow ‘‘e’’). In the presence of limiting antigen,
NF-kB induction may be longer lived, although quantita-
tively lower. Additionally, strong BCR signals may also
activate proapoptotic proteins, such as Bim, that tilt
the balance toward cell death.
Fas-initiated cell death may feature two stages
during the GC reaction. Human GC cells have been
shown to express high levels of Fas and to contain pre-
assembled DISC complex in the cytosol. These cells
also express high levels of c-FLIP, presumably induced
during CD40-dependent proliferation. Because cell
death in culture coincides with loss of c-FLIP, it has
been proposed that GC B cells may be susceptible to
Fas-initiated death by a cell-intrinsic pathway. Thismechanism may also apply in vivo during the decay
phase after each round of proliferation. However, its
contribution to cell death at this stage is probably not
significant or compensated effectively by growth-
factor-withdrawal-induced death. Fas may play a more
prominent role in selecting the highest-affinity BCR
variants prior to subsequent rounds of proliferation,
when expression of CD40-induced protective proteins,
such as c-FLIP, GADD45b, and Bcl-XL, is at its lowest.
At this stage a range of BCR avidities may provide the
initial survival signal against death-by-neglect and thus
maximize the likelihood of encountering T cells. How-
ever, upon the encounter with FasL- and CD40L-bearing
T cells, there may be imposed additional selective pres-
sure from which only cells with the highest-avidity
BCRs, which can counter Fas-mediated cell death, will
emerge. In other words, although the majority of post-
replicative cells die by cell-intrinsic mechanisms, the
presence of Fas would accentuate positive selection
of the highest-avidity B cells. Conversely, unwanted
specificities would emerge in the absence of Fas, as
seen in certain experimental circumstances (Takahashi
et al., 2001).
Conclusion
B cell homeostasis is governed by cell-intrinsic and cell-
extrinsic mechanisms. The importance of proapoptotic
and antiapoptotic proteins that affect mitochondrial in-
tegrity has been convincingly demonstrated by genetic
studies, as has the role of death receptors such
as Fas. Both death pathways are regulated by the
transcription factor NF-kB via inducible expression of
antiapoptotic genes. The goal of this review has been
to provide an understanding of the relationship between
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880the properties of NF-kB and the appropriate control of B
cell apoptosis in the periphery. In particular, I have con-
sidered the kinetics of NF-kB activation, possible differ-
ences between closely related family members REL-
A(p65) and REL, the intersection between the canonical
and noncanonical pathways of NF-kB activation, and
the role of the BCR coreceptor in signaling to NF-kB.
Although the present analysis is mostly restricted to
responses of a small number of single receptors, the
working hypothesis is that the net contribution of the
NF-kB pathway in specific circumstances will be gov-
erned by the combined patterns of NF-kB activation by
individual receptors. Lastly, the cellular milieu in which
the action takes place is obviously much more complex
than the unabashedly NF-kB-centric views described
here; thus, integration of the NF-kB response with other
concurrently operative pathways will be required for
a complete description of the B cell immune response.
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